|
ATCC
mastocytoma cell line p815 Mastocytoma Cell Line P815, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/10__1128_slash_jvi__02298___16-46-52-56?v=ATCC Average 96 stars, based on 1 article reviews
mastocytoma cell line p815 - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
DSMZ
murine cell line p815 ![]() Murine Cell Line P815, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pm31959757-249-1-13?v=DSMZ Average 93 stars, based on 1 article reviews
murine cell line p815 - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
ATCC
mouse mastocytoma line p815 ![]() Mouse Mastocytoma Line P815, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pmc00110314-122-8-12?v=ATCC Average 94 stars, based on 1 article reviews
mouse mastocytoma line p815 - by Bioz Stars,
2026-08
94/100 stars
|
Buy from Supplier |
|
Elabscience Biotechnology
p815 ![]() P815, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pmc11099600-40-6-7?v=Elabscience+Biotechnology Average 92 stars, based on 1 article reviews
p815 - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
Japan SLC inc
p815-hcd20 ![]() P815 Hcd20, supplied by Japan SLC inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/us11617765-314-3-19?v=Japan+SLC+inc Average 90 stars, based on 1 article reviews
p815-hcd20 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
JCRB Cell Bank
p815 cells ![]() P815 Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pmc03697442-115-8-10?v=JCRB+Cell+Bank Average 90 stars, based on 1 article reviews
p815 cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Johns Hopkins HealthCare
mastocytoma line p815 ![]() Mastocytoma Line P815, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pm15322167-72-1-11?v=Johns+Hopkins+HealthCare Average 90 stars, based on 1 article reviews
mastocytoma line p815 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
CEM Corporation
p53 mutation in p-815 selected cell lines ![]() P53 Mutation In P 815 Selected Cell Lines, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pmc08909202-194-8-4?v=CEM+Corporation Average 90 stars, based on 1 article reviews
p53 mutation in p-815 selected cell lines - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Verlag GmbH
p815 tumor cell line ![]() P815 Tumor Cell Line, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pm19189311-190-20-3?v=Verlag+GmbH Average 90 stars, based on 1 article reviews
p815 tumor cell line - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Biofield Corporation
p815 biofield (aura) scanning ![]() P815 Biofield (Aura) Scanning, supplied by Biofield Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/10__1161_slash_circulationaha__108__189874-12760-13-11?v=Biofield+Corporation Average 90 stars, based on 1 article reviews
p815 biofield (aura) scanning - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ScienCell
mouse mast cell line p815 ![]() Mouse Mast Cell Line P815, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pmc08494307-31-0-6?v=ScienCell Average 90 stars, based on 1 article reviews
mouse mast cell line p815 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Microsynth ag
murine p815 cells ![]() Murine P815 Cells, supplied by Microsynth ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p815/pmc11028391-364-4-14?v=Microsynth+ag Average 90 stars, based on 1 article reviews
murine p815 cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Nature communications
Article Title: Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancy.
doi: 10.1038/s41467-019-14123-z
Figure Lengend Snippet: Fig. 6 dNK responses triggered by activating KIR. a Representative XCL1 and CD107a staining by CyTOF in lineage negative (Lin−) CD56+ decidual cells co-expressing 1–3 Killer-cell immunoglobulin-like receptors (KIR) following a 6 h co-culture with K562 (n = 10). b Representative XCL1 and CD107a staining by mass cytometry in Lin-CD56+ cells co-expressing 1–3 KIR following 4 h stimulation by PMA plus ionomycin (n = 8). c Representative XCL1 staining by flow cytometry in Lin-CD56+KIR2DS4+ decidual cells co-expressing 1–3 additional KIRs following activation via P815 cells coated with anti-KIR2DS4 (n = 6). d Correlation of frequency of XCL1+Lin-CD56+ decidual cells and mean side scatter for the same subset (n = 20). Two-tailed p-value calculated for Pearson correlation coefficients. Two-tailed one-way ANOVA of matched data points with Tukey correction and 95% confidence level was used. *p < 0.05, **p < 0.01, ***p < 0.001. Source data are provided as a Source Data file.
Article Snippet: The
Techniques: Staining, Expressing, Co-Culture Assay, Mass Cytometry, Cytometry, Activation Assay, Two Tailed Test
Journal: Biomedical Reports
Article Title: Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression
doi: 10.3892/br.2024.1780
Figure Lengend Snippet: Cytotoxicity of ultravist in P815 cells. P815 cells were incubated with different doses of ultravist for 24 h and cell viability was measured by the CCK-8 test. * P<0.05 vs. control.
Article Snippet: The mouse mast cell cell line,
Techniques: Incubation, CCK-8 Assay, Control
Journal: Biomedical Reports
Article Title: Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression
doi: 10.3892/br.2024.1780
Figure Lengend Snippet: Mast cells could be activated by ultravist stimulation. P815 cells were stimulated with ultravist for 24 h; (A) histamine and (B) β-hexosaminidase were measured by ELISA. * P<0.05, ** P<0.01.
Article Snippet: The mouse mast cell cell line,
Techniques: Enzyme-linked Immunosorbent Assay
Journal: Biomedical Reports
Article Title: Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression
doi: 10.3892/br.2024.1780
Figure Lengend Snippet: miRNA expression profile of ultravist-stimulated mast cells. P815 cells were treated with 50 mg/ml ultravist for 24 h. miRNA from the control and ultravist treatment groups was extracted and analyzed by miRNA array. miRNA/miR, microRNA.
Article Snippet: The mouse mast cell cell line,
Techniques: Expressing, Control
Journal: Biomedical Reports
Article Title: Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression
doi: 10.3892/br.2024.1780
Figure Lengend Snippet: KEGG Pathway Analysis of ultravist-treated mast cells. P815 cells were stimulated with 50 mg/ml ultravist for 24 h. Subsequent KEGG pathway analysis of the mTOR signaling pathway revealed upregulation of genes related to (A) miR-19A-3p and (B) miR-362-3p, which are highlighted in red. KEGG, Kyoto Encyclopedia of Genes and Genomes; miRNA/miR, microRNA.
Article Snippet: The mouse mast cell cell line,
Techniques:
Journal: Biomedical Reports
Article Title: Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression
doi: 10.3892/br.2024.1780
Figure Lengend Snippet: miR-19a-3p and miR-362-3p could be upregulated by ultravist treatment. P815 cells were treated with different doses of ultravist and (A) miR-19a-3p and (B) miR-362-3p were detected by reverse transcription-quantitative PCR. * P<0.05, ** P<0.01. miRNA/miR, microRNA.
Article Snippet: The mouse mast cell cell line,
Techniques: Reverse Transcription, Real-time Polymerase Chain Reaction
Journal: Biomedical Reports
Article Title: Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression
doi: 10.3892/br.2024.1780
Figure Lengend Snippet: Network analysis of miRNA-target interactions in mast cells. P815 cells were stimulated with 50 mg/ml ultravist for 24 h, the predicted interactions between miR-19a-3p and miR-362-3p were analyzed and the key target genes-Aox1, Akap2, and Uba2l were highlighted in yellow. miRNA/miR, microRNA.
Article Snippet: The mouse mast cell cell line,
Techniques:
Journal: Frontiers in Immunology
Article Title: NLRP3 Inflammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis
doi: 10.3389/fimmu.2021.749979
Figure Lengend Snippet: NLRP3 expression was increased by estrogen stimulation via ER-α in MCs. (A) Bar plot of differentially expressed genes (DEGs) from the KEGG pathway enrichment analysis; a comparison between β-estradiol treated P815 cells and the control. (B) A volcano plot was used for visualization of the differentially expressed genes. The gray point in the plot represents genes with no statistical differences (-1< log 2 (FC) < 1, P > 0.05), the red point represents upregulated genes (log 2 (FC) > 1, P < 0.05), and the blue point represents downregulated genes (log 2 (FC) < -1, P < 0.05) with statistical significance. (C) Quantitative PCR analysis of ESR1 in P815 cells after ESR1-specific shRNA transfection. (D) Western blot analysis of ER-α in P815 cell nuclei after stable transfection of ESR1-specific shRNA. (E) Relative quantification of NLRP3 mRNA level in P815 was measured by FPKM reads using RNA-seq. (F) Quantitative PCR analysis NLRP3 mRNA levels in P815 cells treated with β-estradiol after knockdown of ESR1 compared with the negative control. (G) Representative images of immunofluorescence staining for NLRP3 (red) in mast cell line P815 incubated with or without 100 pmol/mL β-estradiol for 24 h Data in (C, D, F) represent three independent experiments. Data are expressed as mean ± SEM. Statistics: Unpaired Student’s t-test. * P < 0.05, ** P < 0.01, *** P < 0.001; ns, statistically not significant.
Article Snippet:
Techniques: Expressing, Real-time Polymerase Chain Reaction, shRNA, Transfection, Western Blot, Stable Transfection, RNA Sequencing Assay, Negative Control, Immunofluorescence, Staining, Incubation
Journal: Frontiers in Immunology
Article Title: NLRP3 Inflammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis
doi: 10.3389/fimmu.2021.749979
Figure Lengend Snippet: ERE sites in the NLRP3 promoter mediated estrogen-induced NLRP3 transcription. (A) ChIP analysis was performed using anti-ER-α or anti-Histone H3 antibody to ascertain the existence of the ERE in the promoter of the NLRP3 gene. The PCR results showed that a 159-bp fragment containing the presumed ERE could be precipitated after P815 cells were treated with β-estradiol for 24 h. (B) The pulled-down band was excised from the gel and sequenced. (C) Schematic diagram of luciferase reporter constructs. Basic-Luc: pGL4-basic plasmid; NLRP3-Luc: pGL4-basic plasmid with the NLRP3 promoter fragment including presumed ERE-like sequence; delNLRP3-Luc: pGL4-basic plasmid with the mutant NLRP3 promoter fragment, with the presumed ERE-like sequence deleted. (D) Luciferase activities of three report systems with or without ESR1 plasmid co-transfection in 293T cells were compared with each other. Renilla luciferase plasmid was used to normalize transfection efficiencies. The experiments were repeated three times and data are presented as means ± SEM. Statistics: Unpaired Student’s t-test. * P < 0.05, ** P < 0.01.
Article Snippet:
Techniques: Luciferase, Construct, Plasmid Preparation, Sequencing, Mutagenesis, Cotransfection, Transfection
Journal: Frontiers in Immunology
Article Title: NLRP3 Inflammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis
doi: 10.3389/fimmu.2021.749979
Figure Lengend Snippet: The NLRP3 inflammasome pathway was activated by estrogen via ER-α. (A) Western blot analysis of NLRP3, cleaved caspase-1, caspase-1 precursor, cleaved IL-1β, IL-1β precursor, and ASC in P815 cells treated with 100 pmol/mL β-estradiol for 1 h, 3 h, 6 h, 12 h, and 24 h. (B) Quantified results of western blot assays. (C) Intracellular concentration of K + was determined by the ratio of the fluorescence intensities obtained by exciting PBFI at 340/380 nm wavelengths while monitoring emission at 500 nm, and presented as percent of untreated control. (D) The concentration of IL-1β in the P815 cell culture supernatant was tested using ELISA. Data in (B–D) represent three independent experiments. Data are expressed as mean ± SEM. Statistics: ANOVA followed by Dunnett t-test. * P < 0.05, ** P < 0.01, *** P < 0.001.
Article Snippet:
Techniques: Western Blot, Concentration Assay, Fluorescence, Cell Culture, Enzyme-linked Immunosorbent Assay
Journal: Cancer Immunology, Immunotherapy : CII
Article Title: Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
doi: 10.1007/s00262-019-02427-4
Figure Lengend Snippet: Expression of PD-1/PD-L1 on HCC tumour tissues and tumour cell lines. a Representative images of immunohistochemistry sections in the tumour tissue of HCC patient #20. Positive cells are stained brown by immunoperoxidase. Arrows mark PD-1-positive mononuclear cells (upper left), CD8+ T cells (upper right) and perforin-positive cells (lower right), respectively. PD-L1 staining shown in the lower-left panel indicates a greater number of positive mononuclear cells (macrophages and CD8+ T cells). Of note, HCC tumour cells did not stain positive for PD-1 and PD-L1. Tu tumour. b The flow cytometric analysis of PD-L1/L2 expression on P815 mouse mastocytoma cells in contrast to various hepatoma cell lines (HepG2, HepT1, Huh4, Hep3B, Huh7). Unlike hepatoma cells, which up-regulated PD-L1 and PD-L2, P815 cells remained PD-L1 and PD-L2 negative in cell culture. Thus, we used P815 cells as target cells in lectin-dependent cellular cytotoxicity (LDCC) assays to study the functional role of Tregs on T cell functions in a model of PD-L1/L2-negative tumour cells
Article Snippet: Cell line authentication of
Techniques: Expressing, Immunohistochemistry, Staining, Cell Culture, Functional Assay
Journal: Cancer Immunology, Immunotherapy : CII
Article Title: Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
doi: 10.1007/s00262-019-02427-4
Figure Lengend Snippet: IFN-gamma production and degranulation by CD8+ T cells in lectin-dependent cellular cytotoxicity (LDCC) assays and effects of checkpoint inhibition. a The gating strategy to analyse IFN-gamma production and T cell degranulation in CD8+ T effector cells by flow cytometry in co-cultures with Con A-loaded P815 cells and Tregs (Treg to Teff ratio: 1:2). b IFN-gamma production (left) and CD107a degranulation (right) of CD8+ T effector cells in LDCC assays before (BL), with exposure to Con A-loaded P815 target cells (stim = peak secretion) and upon adding Tregs (stim + Tregs). Adding autologous Tregs reduced P815-induced peak IFN-gamma secretion and degranulation of CD8+ T cells in all study groups. p values refer to significances obtained by paired Student t test marked by bars. c Provides the summary statistics concerning the differences of IFN-gamma-production (left) and CD107a degranulation (right) by CD8+ T cells after sequential addition of Con A-loaded P815 target cells and autologous Tregs (Treg to Teff ratio: 1:2), as well as in the presence of added neutralizing anti-PD-1, anti-PD-L1, and anti-CTLA-4, and anti-GITR (10 µg/ml each). Columns represent the mean ± SD of 6–18 different donors. Anti-PD-1 and anti-PD-L1—but not anti-CTLA-4 nor anti-GITR—partially reversed Treg-associated inhibition of IFN-gamma secretion in CD8+ T cells from patients with HCC. Treg-mediated inhibition of T cell degranulation was not reversed by any of the antibodies. p values refer to significances obtained by paired Student t test marked by bars
Article Snippet: Cell line authentication of
Techniques: Inhibition, Flow Cytometry